Patent · US Active

Long-acting formulations

US11141384B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Koenraad Jozef Lodewijk Marcel Andries · Beerse, BE
Maristella Bernini · Beerse, BE
Esther Dina Guido Basstanie · Zandhoven, BE

Key dates

Filing date	Jul 13, 2018
Grant date	Oct 12, 2021
Priority date	—
Expiry date	Oct 9, 2038

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB82Y5/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns pharmaceutical compositions for administration via intramuscular or subcutaneous injection, comprising micro- or nanoparticles of the anti-TB compound bedaquiline, suspended in an aqueous pharmaceutically acceptable carrier, and the use of such pharmaceutical compositions in the treatment and prophylaxis of a pathogenic mycobacterial infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.